WINCO ANTIFUNGAL

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: WINCO ANTIFUNGAL
Generic name: TOLNAFTATE 1%
Manufacturer: WinCo Foods LLC
Product type: HUMAN OTC DRUG
SPL set ID: 46b58c71-d62e-4b3d-b2ec-65407032eeea
SPL ID: f27bd705-6df0-4fcd-bc25-0324897f1226
Version: 3
Effective date: 2024-11-21
Source export date: 2026-10-12
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/fb14b8f3d34b45230a84f851c029385f512adf3f002423a9b78d4f7ca626ecec/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:25:46

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M005	openfda.application_number
brand name		WINCO ANTIFUNGAL	openfda.brand_name
generic name		TOLNAFTATE 1%	openfda.generic_name
manufacturer name		WinCo Foods LLC	openfda.manufacturer_name
ndc	package	67091-051-28	openfda.package_ndc
ndc	product	67091-051	openfda.product_ndc
ndc11	package	67091005128	derived:openfda.package_ndc
rxcui		103951	openfda.rxcui
spl id		f27bd705-6df0-4fcd-bc25-0324897f1226	id
spl set id		46b58c71-d62e-4b3d-b2ec-65407032eeea	set_id
unii		06KB629TKV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use on children under 2 years of age unless directed by a doctor. For external use only avoid contact with eyes. Irritation occurs or if there is no improvement within 4 weeks (for athlete's foot and ringworm)irritation occurs or if there is no improvement within 2 weeks (for jock itch).

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.